Competitive Landscape of Hip Replacement Market, Recent Developments, Strategies, Sustainability, Product Launches, Key Persons, and Revenue Forecasts

The Hip Replacement industry is expected to expand lucratively to an estimated value of US$ 10.24 Billion by 2033, from US$ 6.92 Billion in 2024. This expansion reflects a compound annual growth rate (CAGR) of 4.45% between 2025 and 2033.

Hip replacement surgery, sometimes referred to as hip arthroplasty, involves replacing a diseased or injured hip joint with a prosthesis, or artificial joint. People with severe hip joint disorders, such as osteoarthritis, rheumatoid arthritis, avascular necrosis, hip fractures, or other hip-related injuries or conditions, typically undergo the operation to reduce discomfort and increase mobility. Typically, hip replacement surgery is carried out under general anesthesia, and the surgeon may employ minimally invasive procedures or open surgery.

Restoring function and mobility, returning to everyday activities, and enhancing patients' general quality of life are all made possible with hip replacement. Therefore, during the projected period, the growing awareness of these operations and the associated benefits will drive the expansion of the hip replacement market. High rates of hip joint and bone damage are being caused by an increase in obesity and orthopedic issues brought on by sedentary lifestyles, bad eating habits, and a lack of physical activity. Since hip replacement implants can help patients with whole or partial hip injury and injuries, the main factor propelling the market's growth is the rise in the prevalence of these conditions worldwide. The market is also expanding as a result of the rising demand for surgical treatments, the increasing number of fatal traffic accidents, and injuries sustained in sports.

List of Leading Companies in the Hip Replacement Market

Smith & Nephew PLC

Formation: 1856
Head Office: United Kingdom

The medical technology company Smith & Nephew Plc (Smith & Nephew) develops, manufactures, and markets medical devices for use in advanced wound care, sports medicine, orthopedic reconstruction and trauma, and ENT. The company offers sophisticated products and equipment for removing or mending soft tissue, hip, knee, and shoulder replacement systems, robotics-assisted and digital enabling solutions, wound dressings, enhanced wound bio-actives, and advanced wound devices. Under the trademarks Oasis, Opsite, Pico, Primapore, Profore, and Renasys, among others, the company distributes its goods to surgeons, nurses and nurse specialists, doctors and general practitioners, hospital buying experts, and healthcare insurers. The corporation sells its goods across Africa, the Middle East, Asia Pacific, Europe, and the Americas.

Johnson & Johnson

Establishment: 1886
Headquarters: United States

The healthcare company Johnson & Johnson (J&J) is engaged in the creation, manufacturing, marketing, and research of new medications and medical equipment. Through its operating enterprises, it conducts business. It offers medical devices for use in the general surgery, cardiovascular, orthopedic, neurovascular, and vision care markets as well as pharmaceutical medicines used in the treatment of immunological disorders, cancer, neurological disorders, infectious, cardiovascular, and metabolic diseases. The company distributes its goods to hospitals, healthcare providers, distributors, and retailers. The United States, Europe, Asia-Pacific, Africa, the Western Hemisphere (apart from the US), and Latin America are among its manufacturing locations.

Integra lifesciences Corporation

Founding: 1989
Headquarters: United States

The medical technology company Integra LifeSciences Holdings Corp (Integra) creates and produces product lines based on modified collagen. The company's products include tissue-engineered wound dressings, orthopedic hardware and advanced wound care, specialty metal implants, dermal regeneration products, orthobiologic goods, nerve and tendon repair products, and surgical equipment. Its neurosurgery products include brain retraction and cranial stabilization devices, ultrasonic surgery systems, and measurement systems for different brain parameters. Reconstructive and general surgery, neurology, and orthopedic extremities surgery all employ Integra's products. Integra markets to doctors' offices, veterinary clinics, dentistry offices, and outpatient surgery centers. The company uses a large global network of distributors and direct sales reps to distribute its products.

Zimmer Biomet

Founding: 1927
Headquarters: United States

The medical device business Zimmer Biomet Holdings Inc. (Zimmer Biomet) focuses on musculoskeletal care. The company develops, manufactures, and markets associated surgical goods, office-based technologies, a suite of integrated digital and robotic technologies, orthopedic reconstructive products, biologics, sports medicine, extremities, and trauma products. Patients with diseases or injuries of the bones, joints, and supporting soft tissues can benefit from its products and remedies. In addition to other professions, Zimmer Biomet offers their products to hospitals, healthcare dealerships, healthcare purchasing groups, neurosurgeons, orthopedic surgeons, and stocking distributors. In the Americas, Europe, Asia-Pacific, the Middle East, and Africa, Zimmer Biomet distributes its goods through distributors and direct sales channels.

Stryker

Creation: 1941
HQ: United States

A medtech business, Stryker Corp. (Stryker) specializes in producing orthopedic, medical and surgical, neurotechnology, and spine devices. Orthopedic implants, surgical tools and surgical navigation systems, endoscopic and communications systems, patient management, emergency medical equipment, and disposables for critical care are its main products. Additionally, it offers spinal, neurovascular, and neurosurgical instruments as well as medical gadgets for a variety of ailments. Stryker sells its goods to hospitals, doctors' offices, and other healthcare facilities. In the Americas, Europe, Asia-Pacific, the Middle East, and Africa, the business distributes its goods through subsidiaries, branches, independent dealerships, and distributors.

Sustainability Analysis of Hip Replacement Market

ConMed Corporation

DSM’s Sustainability Profile

ConMed Corporation, a leading medical technology company specializing in surgical instruments, has demonstrated a growing commitment to sustainability through its Environmental, Social, and Governance (ESG) initiatives. The company has established a comprehensive ESG program that is cross-functional and global in nature, with oversight from the ConMed Corporation Board of Directors. This program includes efforts to reduce energy consumption, implement water-saving measures, and source eco-friendly materials where possible.

Strength: Commitment to Carbon Reduction

ConMed has set ambitious carbon reduction goals, aiming to achieve a 90% reduction in Scope 1, 2, and a subset of Scope 3 emissions by 2050, using a 2023 baseline. These targets are part of the company's broader ESG strategy, which includes initiatives to reduce energy consumption, implement water-saving measures, and source eco-friendly materials.

SWOT Analysis of Hip Replacement Market

Exactech, Inc. Strength Analysis

Established Product Portfolio and Global Presence

Exactech, Inc. is a prominent player in the orthopedic medical device sector, specializing in joint replacement implants, surgical instruments, and smart technologies. The company has developed a comprehensive product portfolio encompassing hip, knee, shoulder, and ankle implants, which are distributed globally. Exactech's products are designed to enhance surgical outcomes and improve patient mobility, positioning the company as a trusted partner in the medical community. The company's extensive experience and established relationships with healthcare providers contribute to its strong market presence and reputation for quality and innovation.

Exactech, Inc. Opportunity Analysis

Post-Bankruptcy Restructuring and Market Rebuilding

Due to litigation and recall-related financial strains, Exactech has exited bankruptcy under a new ownership structure led by Strategic Value Partners and Stellex Capital Management. This transition presents an opportunity for Exactech to rebuild its brand and operations. By focusing on product quality, regulatory compliance, and transparent communication, Exactech can restore stakeholder trust and capitalize on the growing demand for orthopedic solutions. Additionally, the company can explore strategic partnerships and investments to accelerate innovation and expand its market share in the global orthopedic device industry.

Arthrex, Inc. Strength Analysis

Market Leadership in Minimally Invasive Orthopedic Solutions

Arthrex, Inc. has established itself as a global leader in the orthopedic medical device industry, particularly renowned for its innovations in minimally invasive surgery. The company develops and releases over 1,000 new products and procedures annually, encompassing various specialties such as shoulder, knee, elbow, hand and wrist, foot and ankle, and hip-related surgical products, orthobiologics, and imaging and resection systems. This robust product portfolio underscores Arthrex's commitment to advancing surgical techniques and improving patient outcomes. Additionally, Arthrex's dedication to medical education and training programs ensures that healthcare professionals are equipped with the latest knowledge and skills, further solidifying its position as a trusted partner in the medical community.

Arthrex, Inc. Opportunity Analysis

Expansion into Emerging Markets

As global healthcare demands evolve, Arthrex has a significant opportunity to expand its presence in emerging markets where access to advanced medical technologies is increasing. By strategically entering these regions, Arthrex can tap into a growing patient base and collaborate with local healthcare providers to enhance surgical capabilities. Establishing partnerships, providing training programs, and adapting products to meet regional needs can facilitate market penetration. Furthermore, leveraging digital platforms for education and remote support can overcome geographical barriers, ensuring that healthcare professionals in emerging markets benefit from Arthrex's expertise. This expansion aligns with the company's mission to improve patient care globally and presents a pathway for sustained growth in the orthopedic sector.

Medacta International SA Strength Analysis

Innovation in Orthopedic Solutions

Medacta International SA’s key strength lies in its commitment to innovation within the orthopedic sector. The company specializes in minimally invasive surgical solutions and personalized procedures, such as patient-matched implants and advanced kinematic alignment techniques. By focusing on high-quality, precision-engineered products, Medacta has built strong credibility among surgeons and healthcare providers. Its investment in research and development enables continuous product improvements and the introduction of novel surgical technologies, keeping it ahead of competitors. Additionally, the company emphasizes surgeon education and training programs, ensuring proper adoption and effective use of its solutions. This integrated approach - combining innovative products with professional support - enhances customer loyalty, strengthens its market reputation, and positions Medacta as a trusted leader in the orthopedic medical device industry.

Medacta International SA Opportunity Analysis

Expansion in Personalized and Minimally Invasive Surgery

Medacta has a significant opportunity to capitalize on the growing demand for personalized and minimally invasive orthopedic procedures. As healthcare providers and patients increasingly seek tailored solutions that improve surgical outcomes and recovery times, Medacta can leverage its expertise in patient-matched technologies and advanced surgical techniques. Expanding its global reach, forming strategic partnerships, and increasing access to training and educational programs can further enhance adoption of its solutions. Moreover, growing awareness of the benefits of minimally invasive surgery presents the company with opportunities to innovate in surgical instruments, navigation systems, and related services. By pursuing these avenues, Medacta can strengthen its competitive position and contribute to advancing patient-centric orthopedic care.

Recent Developments in Hip Replacement Market

• In May 2025, Zimmer Biomet reported a 0.9% increase in Q1 hip revenue of USD 495.8 million and said that surgeons were responding well to the Z1 Triple-Taper Femoral Hip System and HAMMR Automated Impactor.
• April 2025: Despite early progress for CATALYSTEM Primary Hip and FDA approval of LEGION Medial Stabilized inserts, Smith+Nephew announced Q1 sales of USD 1.407 billion; hip revenues fell 1.2% due to headwinds in China.
• In March 2025, Johnson & Johnson MedTech unveiled the KINCISE 2 automated impaction device to lessen surgeon fatigue and offered the VELYS Robotic-Assisted Solution clearance for unicompartmental knee.

Hip Replacement Market & Forecast

• Historical Trends
• Forecast Analysis

Market Share Analysis

Company Analysis

Overview

• Company History and Mission
• Business Model and Operations
• Workforce

Key Persons

• Executive Leadership
• Operational Management
• Division Leaders
• Board Composition

Recent Development & Strategies

• Mergers & Acquisitions
• Partnerships
• Investments

Sustainability Analysis

• Renewable Energy Adoption
• Energy-Efficient Infrastructure
• Use of Sustainable Packaging Materials
• Water Usage and Conservation Strategies
• Waste Management and Circular Economy Initiatives

Product Analysis

• Product Profile
• Quality Standards
• Product Pipeline
• Product Benchmarking

Strategic Assessment: SWOT Analysis

• Strengths
• Weaknesses
• Opportunities
• Threats

Revenue Analysis

The above information will be available for all the following companies:

• Smith & Nephew PLC
• Johnson & Johnson
• Integra lifesciences Corporation
• Zimmer Biomet
• Stryker
• B. Braun Melsungen AG
• Globus Medical Inc.
• MicroPort Scientific Corporation
• Conformis Inc.
• Exactech, Inc.
• Arthrex, Inc.
• Medacta International SA
• ConMed Corporation
• Corin Group PLC
• DJO Global, Inc
• Aesculap Implant Systems, LLC
• OMNIlife Science, Inc.
• Wright Medical Group
• LimaCorporate
• Mathys Ltd Bettlach